Fluor vs China National Nuclear Power: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Fluor Corporation (FLR)

Q3 202623 Jun – 7 Aug 2026

▲3▼1

Fluor wins major contracts but cuts 2026 profit outlook

New contract wins boost demand Fluor won a long-term Aramco agreement and a Bahrain petrochemical design deal, plus a small feasibility study. These add to its backlog and show steady demand for its engineering services, which supports future revenue and the stock price.
These new contracts are fresh demand drivers that directly support Fluor's revenue outlook.
Q2 earnings beat and record new awards Fluor reported Q2 revenue of $4.3 billion and adjusted EPS of $0.91, both above expectations. New awards jumped to $6.1 billion from $1.8 billion a year ago, pushing the stock to a 52-week high. This shows strong business momentum.
The earnings beat and record awards are the main positive catalyst this period, directly lifting investor confidence.
2026 profit guidance cut on Mexico JV exit Fluor narrowed its 2026 adjusted EBITDA guidance to $500–$525 million from $525–$560 million, after removing the expected second-half contribution from its Mexico joint venture, which it divested for $175 million. This signals slightly lower profit expectations.
The guidance cut is a real counterweight that could pressure the stock despite strong contract wins.
Analyst optimism on earnings growth Analysts expect Fluor's adjusted EPS to grow 18% in 2026 and 28% in 2027, helped by a shift to reimbursable contracts and a large gain from selling its NuScale stake. They see the stock potentially rising 28% over the next year.
This analyst view highlights the earnings growth story that underpins the positive long-term outlook for FLR.

July 202623 Jun – 7 Aug 2026

▲3▼1

Fluor wins major contracts but cuts 2026 profit outlook

New contract wins boost demand Fluor won a long-term Aramco agreement and a Bahrain petrochemical design deal, plus a small feasibility study. These add to its backlog and show steady demand for its engineering services, which supports future revenue and the stock price.
These new contracts are fresh demand drivers that directly support Fluor's revenue outlook.
Q2 earnings beat and record new awards Fluor reported Q2 revenue of $4.3 billion and adjusted EPS of $0.91, both above expectations. New awards jumped to $6.1 billion from $1.8 billion a year ago, pushing the stock to a 52-week high. This shows strong business momentum.
The earnings beat and record awards are the main positive catalyst this period, directly lifting investor confidence.
2026 profit guidance cut on Mexico JV exit Fluor narrowed its 2026 adjusted EBITDA guidance to $500–$525 million from $525–$560 million, after removing the expected second-half contribution from its Mexico joint venture, which it divested for $175 million. This signals slightly lower profit expectations.
The guidance cut is a real counterweight that could pressure the stock despite strong contract wins.
Analyst optimism on earnings growth Analysts expect Fluor's adjusted EPS to grow 18% in 2026 and 28% in 2027, helped by a shift to reimbursable contracts and a large gain from selling its NuScale stake. They see the stock potentially rising 28% over the next year.
This analyst view highlights the earnings growth story that underpins the positive long-term outlook for FLR.

Latest23 Jun – 7 Aug 2026

▲3▼1

Fluor wins major contracts but cuts 2026 profit outlook

New contract wins boost demand Fluor won a long-term Aramco agreement and a Bahrain petrochemical design deal, plus a small feasibility study. These add to its backlog and show steady demand for its engineering services, which supports future revenue and the stock price.
These new contracts are fresh demand drivers that directly support Fluor's revenue outlook.
Q2 earnings beat and record new awards Fluor reported Q2 revenue of $4.3 billion and adjusted EPS of $0.91, both above expectations. New awards jumped to $6.1 billion from $1.8 billion a year ago, pushing the stock to a 52-week high. This shows strong business momentum.
The earnings beat and record awards are the main positive catalyst this period, directly lifting investor confidence.
2026 profit guidance cut on Mexico JV exit Fluor narrowed its 2026 adjusted EBITDA guidance to $500–$525 million from $525–$560 million, after removing the expected second-half contribution from its Mexico joint venture, which it divested for $175 million. This signals slightly lower profit expectations.
The guidance cut is a real counterweight that could pressure the stock despite strong contract wins.
Analyst optimism on earnings growth Analysts expect Fluor's adjusted EPS to grow 18% in 2026 and 28% in 2027, helped by a shift to reimbursable contracts and a large gain from selling its NuScale stake. They see the stock potentially rising 28% over the next year.
This analyst view highlights the earnings growth story that underpins the positive long-term outlook for FLR.

China National Nuclear Power (601985.CG)

Q3 202631 Jul – 29 Aug 2026

▲3▼1

New nuclear approvals lift pipeline, but first-half profit drops sharply

Four new nuclear units approved for China National Nuclear Power The State Council approved Liaoning Zhuanghe Units 1-2 and Zhejiang Jinqimen Units 3-4, both using Hualong One reactors. More approved units mean a bigger long-term project pipeline and future earnings for the company.
This is the main new positive force expanding the company's growth pipeline.
10.3 billion yuan procurement for high-temperature reactor project A subsidiary plans to buy contracting services for the Jiangsu Xuwei nuclear heating and power plant's high-temperature reactor phase one. The large order shows the project is moving forward, which supports future revenue for the parent.
It shows concrete project progress that can add future revenue.
First-half profit fell 35.74% on weaker revenue Net profit dropped to 3.641 billion yuan and revenue fell 6.28%. Second-quarter profit also slipped versus the first quarter. Weaker earnings weigh on the stock because investors pay for current profits, not just future projects.
This is the main new negative force and a real counterweight to the approval news.
170 billion yuan of nuclear investment approved nationwide The four approved projects total eight units and over 170 billion yuan of investment, the first batch under the 15th Five-Year Plan. This signals strong state support for nuclear power, helping the whole sector including this company.
It shows the policy backdrop that supports the company's long-term growth.

August 202631 Jul – 29 Aug 2026

▲3▼1

New nuclear approvals lift pipeline, but first-half profit drops sharply

Four new nuclear units approved for China National Nuclear Power The State Council approved Liaoning Zhuanghe Units 1-2 and Zhejiang Jinqimen Units 3-4, both using Hualong One reactors. More approved units mean a bigger long-term project pipeline and future earnings for the company.
This is the main new positive force expanding the company's growth pipeline.
10.3 billion yuan procurement for high-temperature reactor project A subsidiary plans to buy contracting services for the Jiangsu Xuwei nuclear heating and power plant's high-temperature reactor phase one. The large order shows the project is moving forward, which supports future revenue for the parent.
It shows concrete project progress that can add future revenue.
First-half profit fell 35.74% on weaker revenue Net profit dropped to 3.641 billion yuan and revenue fell 6.28%. Second-quarter profit also slipped versus the first quarter. Weaker earnings weigh on the stock because investors pay for current profits, not just future projects.
This is the main new negative force and a real counterweight to the approval news.
170 billion yuan of nuclear investment approved nationwide The four approved projects total eight units and over 170 billion yuan of investment, the first batch under the 15th Five-Year Plan. This signals strong state support for nuclear power, helping the whole sector including this company.
It shows the policy backdrop that supports the company's long-term growth.

Latest31 Jul – 29 Aug 2026

▲3▼1

New nuclear approvals lift pipeline, but first-half profit drops sharply

Four new nuclear units approved for China National Nuclear Power The State Council approved Liaoning Zhuanghe Units 1-2 and Zhejiang Jinqimen Units 3-4, both using Hualong One reactors. More approved units mean a bigger long-term project pipeline and future earnings for the company.
This is the main new positive force expanding the company's growth pipeline.
10.3 billion yuan procurement for high-temperature reactor project A subsidiary plans to buy contracting services for the Jiangsu Xuwei nuclear heating and power plant's high-temperature reactor phase one. The large order shows the project is moving forward, which supports future revenue for the parent.
It shows concrete project progress that can add future revenue.
First-half profit fell 35.74% on weaker revenue Net profit dropped to 3.641 billion yuan and revenue fell 6.28%. Second-quarter profit also slipped versus the first quarter. Weaker earnings weigh on the stock because investors pay for current profits, not just future projects.
This is the main new negative force and a real counterweight to the approval news.
170 billion yuan of nuclear investment approved nationwide The four approved projects total eight units and over 170 billion yuan of investment, the first batch under the 15th Five-Year Plan. This signals strong state support for nuclear power, helping the whole sector including this company.
It shows the policy backdrop that supports the company's long-term growth.